ARAMIS : Efficacy and safety phase 3 trial of ODM-201 in men with high-risk nonmetastatic castration-resistant prostate cancer

  • Karim Fizazi (Contributor)
  • Neal Shore (Contributor)
  • Tammela, T. (Contributor)
  • Toni Sarapohja (Contributor)
  • Annamari Vuorela (Contributor)
  • Iris Kuss (Contributor)
  • Amir Snapir (Contributor)
  • Matthew Smith (Contributor)

    Activity: Talk or presentationConference presentation


    Contributors: Fizazi Karim, Shore Neal, Tammela Teuvo, Sarapohja Toni, Vuorela Annamari, Kuss Iris, Snapir Amir, Smith Matthew
    Period4 Jun 2016
    Event titleASCO Annual Meeting
    Event typeOther
    Degree of RecognitionInternational